Nabriva Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 32.2%.

Top 25 shareholders own 9.7% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.64%	Lincoln Park Capital, LLC	180,504	€262.1k	0%	3.85%
0.81%	Values First Advisors, Inc.	25,868	€37.6k	-0.09%	0.03%
0.72%	Renaissance Technologies LLC	23,061	€33.5k	12.2%	no data
0.7%	Susquehanna International Group, LLP, Asset Management Arm	22,294	€32.4k	0%	no data
0.53%	Frazier Life Sciences Management, LP	17,025	€24.7k	0%	no data
0.44%	Universal-Investment-Gesellschaft Mit BeschrÄNkter Haftung	14,000	€20.3k	0%	no data
0.26%	Theodore Schroeder	8,483	€12.3k	-31.8%	no data
0.14%	Morgan Stanley, Investment Banking and Brokerage Investments	4,438	€6.4k	-0.87%	no data
0.14%	Medical Strategy GmbH, Asset Management Arm	4,389	€6.4k	0%	no data
0.062%	Triad Hybrid Solutions, LLC	2,000	€2.9k	0%	no data
0.052%	Geode Capital Management, LLC	1,661	€2.4k	-0.18%	no data
0.043%	Colin Broom	1,369	€2.0k	-6.3%	no data
0.041%	Steven Gelone	1,323	€1.9k	-90.8%	no data
0.031%	UBS Asset Management AG	992	€1.4k	160%	no data
0.019%	Charles Rowland	610	€885.6	-0.16%	no data
0.014%	Stephen Webster	456	€662.0	-0.44%	no data
0.013%	Daniel Burgess	415	€602.5	0%	no data
0.012%	Carrie Bourdow	396	€575.1	-0.25%	no data
0.011%	Lisa Dalton	364	€528.6	0%	no data
0.0095%	Robert Crotty	305	€443.0	0%	no data
0.009%	Mark H. Corrigan	288	€418.4	0%	no data
0.0088%	J. Naftzger	280	€406.8	0%	no data
0.0029%	Merrill Lynch & Co. Inc., Banking Investments	92	€133.4	76.9%	no data
0.00062%	RBC Dominion Securities Inc., Asset Management Arm	20	€28.8	0%	no data
0.00025%	Tower Research Capital LLC	8	€11.6	0%	no data